![univ-pennsylvania-thumb.jpg University of Pennsylvania](/-/media/_/images/universities/university-research/univ-pennsylvania-thumb.jpg?h=75&w=135&la=en&hash=C320CCDEBD613D9A2F294ABC3AA08F4156D8973A9FF2D7DB7B8814FAB641FBFB)
PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It
Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to PARP inhibitors in patients with ovarian cancer – and they’ve also proven they have a way to see that feature using PET imaging.
Read more about PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It